Background. Uterine leiomyosarcomas are highly aggressive tumors with a poor prognosis. The main prognostic factors are the stage of the disease, the size of the primary tumor, and the grade of malignancy. It is well known that the clinical course and prognosis of uterine leiomyosarcoma do not correlate with the FNCLCC histological grade, based on assessment of the mitotic index and the presence and amount of necrosis in sarcomas. There is published data on a more unfavorable course of non-spindle cell uterine leiomyosarcomas.

Aim. To evaluate the influence of pathological factors (histological subtype, mitotic index, necrosis and its type) on survival rates in uterine leiomyosarcoma.

Materials and methods. The study included 58 patients who underwent radical surgery for uterine leiomyosarcoma. The following morphological parameters were evaluated on histological slides: histological subtype, mitotic index, the presence of necrosis in the tumor and its type. Further, the analysis of the influence of these morphological characteristics on the indicators of progression-free survival and overall survival was carried out. Statistical analysis was carried out using the IBM SPSS Statistics Professional 20.0 statistical software package. Long-term results are presented in the form of actuarial survival calculated by the Kaplan–Meier method.

Results. Most cases of uterine leiomyosarcoma were of the spindle-cell variant (82.8 %), had a mitotic index >20 per 10 high power field (93.1 %) and large foci of necrosis (70.7 %), coagulation necrosis was more often detected (43.1 %). There was a significant difference in the median overall survival of patients with spindle-cell variant of uterine leiomyosarcoma and non-spindle-cell variants (epithelioid or myxoid): 77 months vs. 49 months (p = 0.05). There was no significant relationship between the mitotic index of the primary tumor, the size of necrosis foci in the tumor and survival rates. The presence of coagulative necrosis in the tumor was significantly associated with a deterioration in progression-free survival (9 months vs. 14 months, p = 0.05) and overall survival (51 months vs. 104 months, p = 0.05).

Conclusion. The spindle-cell variant of leiomyosarcoma is associated with higher overall survival rates compared to other histological subtypes. The presence of coagulative necrosis in the tumor in comparison with other types of necrosis is an unfavorable prognostic factor associated with a decrease in both progression-free survival and overall survival.

Background. Salvage radiation therapy is the “gold standard” of treatment for patients with recurrent prostate cancer after radical prostatectomy. However, the results of the effectiveness of salvage radiation therapy in patients with regional recurrences are significantly lower than in patients with local one of prostate cancer, and, as a rule, the progression of the disease more often continues lymphogenic, affecting the next barrier of lymph outflow – retroperitoneal lymph nodes.

Aim. To develop a new more effective radical method of salvage radiation therapy in patients with regional relapses of prostate cancer after radical prostatectomy.

Materials and methods. The radiotherapy department of the N. N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia has developed a new method of hypofractionation salvage radiation therapy of patients with regional recurrences of prostate cancer after radical prostatectomy, which includes treatment not only to regional recurrences, the bed of prostate and regional lymph nodes of the pelvis, but also and prophylactic radiation treatment to retroperitoneal lymph nodes.

Results. 25 patients were treated with prophylactic radiation treatment to retroperitoneal lymph nodes from 2018 to 2021. The median follow-up of patients was 19 (7–22) months. In all patients, radiotherapy was performed in combination with hormone therapy with analogues of luteinizing hormone releasing hormone with a median duration of administration of 8 (6–10) months. All patients were treated without interruption according to the previously planned dosimetric treatment plans. At the end of the course of radiation therapy, none of the patients had any pronounced negative effects of the III–IV degree (according to the RTOG /EORTC scale). The 1-year local and biochemical control of the disease were 100 and 88 %, respectively.

Conclusions. Initial data assessing the safety of the newly developed salvage radiation therapy technique in hypofractionation mode with additional prophylactic of retroperitoneal lymph nodes demonstrate good tolerability. However, further study and randomized phase III clinical trial are required to determine clinical efficacy.

Purpose of the study. To study the frequency and risk factors for the development of colorectal anastomosis leakage after anterior rectal resection for cancer.

Materials and Methods. In a retrospective cohort study between April 2011 and February 2018. The data of the case histories of patients who underwent combined treatment for rectal cancer were analyzed. The study included patients who underwent neoadjuvant chemoradiotherapy followed by surgery. The influence of risk factors on the incidence of AN was assessed based on multivariate analysis using the logistic regression method.

Results. The study was conducted in 474 patients who underwent anterior resection for rectal cancer. Depending on the outcome of the operation, the patients were divided into two groups: with the formation of a preventive intestinal stoma (main group, n = 344) and without formation (control group, n = 140) The overall incidence of postoperative complications was 20.6 % in patients with preventive stoma (PS) and 26.1 % without PS (p = 0.198). Colorectal anastomosis (RCA) leaks were detected in 40 (11.6 %) patients in the PS group and in 9 (6.9 %) patients in the non-PS group (р = 0,134). This complication was detected on the 7th day (2–12 days) after the operation in 5 (9.8 %) patients, while in patients with PS on the 10th day (11.6 %) and without PS on 3 (6.9 %) %), (p = 0.134). According to the classification of NCA severity, grade A was detected in 12 patients, B – at 24, C – in 11 patients. The frequency of reoperations in patients with PS was 10.8 %, while in patients with PS it was 15 % (p <0.001). The most common reason for reoperations in patients with LCA in the group without PS was the development of peritonitis (5.4 %, p <0.001). In a statistical multivariate analysis, the most significant risk factors for the development of NCA were: the presence of preoperative chemoradiotherapy (p = 0.001), diabetes mellitus (p = 0.031) and stage III–IV of the disease (p = 0.051).

Conclusions. The formation of a preventive intestinal stoma after anterior resections does not reduce the incidence of colorectal anastomosis leaks (p = 0.134), however, it reduces the degree of manifestation of AN in the severity of the course of the postoperative postoperative period (p = 0.029). The frequency of reoperations in patients without a PS is significantly higher than in patients with a stoma (p <0.0001). Diabetes mellitus, chemoradiotherapy, and stage III–IV of the disease are factors influencing the development of leakage.

Colorectal cancer is a significant group of malignant neoplasms that dominates the morbidity and mortality patterns in the world. for patients with colorectal cancer, a multidisciplinary approach is required when choosing treatment tactics involving surgeons, radiotherapists and chemotherapists. At present, it is impossible to overestimate the role of radiotherapy in the treatment of locally advanced rectal cancer. The purpose of this review is to summarize current data on proton beam therapy and its role in the treatment of rectal cancer.

One of the possible adverse events of cervical cancer arising both as a result of the progression of the disease and as a result of the treatment, leading to a significant decrease in the quality of life, is the development of genital fistulas. This review presents current information on diagnostic approaches, and treatment options for fistulas caused by cervical cancer. The peculiarities of fistulas that have arisen after radiation therapy and surgical treatment are highlighted.

Background. The results of local destruction methods in locally advanced pancreatic cancer (LAPCa) are contradictory. Radiation therapy is the most commonly used. Other methods are used much less frequently, irreversible electroporation (IRE) is one of them. Most authors indicate an acceptable level of complications and mortality, but without an improvement in long-term results. The results of two meta-analyses have been published, the authors indicate the possibility of using the IRE in selected patients. The authors also point out that minimally invasive methods of using the IRE be preferred. Some experience has been gained in the use of percutaneous access for IRE in LAPCa. Computed tomography, ultrasound guidance can be used for navigation. The level of complications can reach 50 %. Mortality with percutaneous access, as a rule, is absent or does not exceed 5 %. Long-term results are the same with the results of open IRE.

Aim. To share authors experience of using percutaneous irreversible electroporation in pancreatic cancer, because there are no references to the use of percutaneous IRE in LAPCa in Russia.

Materials and methods. The IRE was performed for 53-year female patient with LAPCa after successful induction therapy. A step-by-step pulse effect of electrodes installed under ultrasound control on the tumor infiltrate was carried out. Magnetic resonance imaging, computed tomography and other types of studies were used for diagnostic purposes.

Results. The involvement of the common hepatic artery and portal vein remained after the induction therapy, which did not allow performing pancreatoduodenal resection. Ultrasonic navigation and flat-detector computed tomography allowed to install the electrodes adequatly and safely. The impact zone almost completely blocked the infiltrate zone, a more optimal location of the electrodes was limited by the wide network of venous collaterals. Magnetic resonance imaging data performed before and after the procedure showed no progression of the disease within more than three months after the procedure, including in the affected area. Tumor shrinkage was noted as a partial response.

Conclusion. The first experience confirmed the safety and the absence of subsequent complications when using the percutaneous access method of IRE for LAPCa. Follow-up monitoring of the patient will allow to say more correctly about the possibility of the method to provide long-term local control.

Tumoural portal vein thrombosis is a rare manifestation in gastric cancer. There is no reliable information in the worldwide literature on the overall survival of this category of patients. Few clinical cases have been described. This is a clinical case: a patient has diagnosed with body and antral gastric cancer complicated by tumour thrombosis of the portal vein and ingrowth into the pancreas. The clinical case described by the authors demonstrates yours the relevance of a number of issues. How can we namely be staging, treatment options and prognosis. The aim of this publication is to draw attention to a rare but common category of patient in oncologists’ clinical practice.